# CORRESP — GT Biopharma, Inc.  (GTBP)  (CIK 0000109657)

> <strong>GT Biopharma, Inc.  (GTBP)  (CIK 0000109657) → SEC staff</strong> · filed 2026-05-11 · ticker GTBP · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-022183
- **Form:** CORRESP
- **Filer:** GT Biopharma, Inc.  (GTBP)  (CIK 0000109657)
- **CIK:** 0000109657
- **Ticker:** GTBP
- **Filed:** 2026-05-11
- **SIC industry:** 2834
- **HQ:** San Francisco, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/109657/000149315226022183/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=109657&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for GT Biopharma, Inc.  (GTBP)  (CIK 0000109657)

- UPLOAD — 2026-05-06 — /comment-letter/0000000000-26-004634
- CORRESP — 2026-01-28 — /comment-letter/0001493152-26-003958
- UPLOAD — 2026-01-27 — /comment-letter/0000000000-26-000990
- CORRESP — 2025-12-02 — /comment-letter/0001493152-25-025711

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, GT Biopharma, Inc.  (GTBP)  (CIK 0000109657) (CIK 0000109657), filed 2026-05-11, accession 0001493152-26-022183. Retrieved via MORVS 2026-11-15 from https://api.morvs.ai/comment-letter/0001493152-26-022183.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*